Back to search results

Rural Telehealth for Opioid Use Disorder Treatment

This study aims to improve access to opioid use disorder (OUD) treatment in rural Georgia by using telehealth. It tests a new approach where medical toxicologists (doctors specializing in poisons) at the Georgia Poison Center work with rural emergency departments (EDs) and peer recovery coaches (people with lived experience who support others in recovery) to start buprenorphine, a medication for OUD (MOUD). The study will enroll 480 participants who are 18 or older, speak English, are clinically sober, and medically stable. Success will be measured by changes in the number of patients experiencing opioid withdrawal or overdose, or requesting OUD treatment, and the number of patients evaluated for and started on MOUD. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 480 participants. It involves a collaboration between rural EDs, medical toxicologists, and peer recovery coaches.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for changes in their condition at 3 months and 1 year after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05711056

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment

Recruiting
NAAges 18+InterventionalTreatment
Emory University
~480 participants
Updated 2025-10-20 on ClinicalTrials.gov
What's tested:Sociobehavioral Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in number of patients who present with acute opioid withdrawal, acute opioid overdose, or requesting treatment for OUD (Opioid Use Disorder)
Measured over Baseline, 3 months post intervention, and 1 year post intervention
+5 more outcomes measured

Conditions

Opioid Use
Opioid Abuse

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Georgia1

Study leadership

  • Emily Kiernan, DO · PRINCIPAL_INVESTIGATOR · Emory University

Who to contact

Emily Kiernan, DO
[email protected]
412-519-4944
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
English speaking
Clinically sober
Medically and psychiatrically stable

Exclusion

Already receiving MAT or psychotherapy for OUD prior to ED arrival
Prior participation in the study
Unable to provide informed consent
If their clinical condition worsens such that continued participation would be considered unsafe in the opinion of the PRC or ED staff
Prisoners
Individuals who are not yet adults (infants, children, teenagers)
Cognitively impaired or Individuals with Impaired Decision-Making Capacity
Individuals who are not able to clearly understand English

What this trial measures

  • Change in number of patients who present with acute opioid withdrawal, acute opioid overdose, or requesting treatment for OUD (Opioid Use Disorder)Baseline, 3 months post intervention, and 1 year post intervention

    Change in number of patients who present with acute opioid withdrawal, acute opioid overdose, or requesting treatment for OUD will be collected

  • Change in number of patients evaluated for MOUD (Medication for Opioid Use Disorder)Baseline, 3 months post intervention, and 1 year post intervention

    Change in number of patients evaluated for MOUD will be collected

  • Change in number of patients started on MOUDBaseline, 3 months post intervention, and 1 year post intervention

    Change in number of patients started on MOUD will be collected

  • Change in number of patients discharged with a prescription for MOUDBaseline, 3 months post intervention, and 1 year post intervention

    Change in number of patients discharged with a prescription for MOUD will be collected

  • Change in number of patients linked to a local RCO (Recovery Community Organization)Baseline, 3 months post intervention, and 1 year post intervention

    Change in number of patients linked to a local RCO will be collected

  • Change in number of patients seen at local RCO after ED dischargeBaseline, 3 months post intervention, and 1 year post intervention

    Change in number of patients seen at local RCO after ED discharge will be collected